XM does not provide services to residents of the United States of America.

Indian benchmarks slide as IT stocks, derivatives expiry weigh



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian benchmarks slide as IT stocks, derivatives expiry weigh</title></head><body>

Updates for markets close

By Bharath Rajeswaran

Nov 28 (Reuters) -India's benchmark indexes posted their steepest declines in nearly two months on Thursday, dragged down by heavyweight IT firms and as investors adjusted positions due to the expiry of monthly derivatives contracts.

The NSE Nifty 50 .NSEI fell 1.49% to 23,914.15, while the BSE Sensex .BSESN lost 1.48% to 79,043.74.

The Nifty 50 monthly derivatives series expired on Thursday, which meant that investors have to close or roll over their contracts. The Bank Nifty derivatives contracts expired on Wednesday.

The small- .NIFSMCP100 and mid-caps .NIFMDCP100 bucked the weakness to end little changed as they have no derivatives and minimal exposure to IT stocks.

"The decline in markets today is mainly due to the expiry pressure of the current month's futures and options contracts," said Shrikant Chouhan, head of equity research at Kotak Securities.

IT stocks .NIFTYIT tumbled 2.39% after U.S. inflation and consumer spending data overnight suggested interest rate cuts could be slower than expected. That could impact spending by clients in the U.S., a key market for IT companies.

" ... (the) market seems to have found an excuse for profit booking in IT stocks," said Santosh Meena, head of research at Swastika Investmart.

The IT index has rallied about 9% this month, while the Nifty has gained just 0.3%.

Among individual stocks, Adani Enterprises ADEL.NS, the Adani Group's flagship firm, rose 1.6%. Adani Green Energy ADNA.NS and Adani Energy Solutions ADAI.NS jumped 10% each.

Adani Total Gas ADAG.NS surged 16% as the conglomerate's stocks continued their rebound from a selloff that was triggered by the U.S. indictment of the group's founder last week. The Group has denied all allegations.

Insurers SBI Life SBIL.NS fell 5.1% and HDFC Life HDFL.NS lost 3.4%, the most on the Nifty, after a media report said the insurance regulator may consider a cap on insurers selling products to their parent bank's clients.

That dragged financials .NIFTYFIN by about 0.75%.


India's Nifty 50 posts worst session since early October https://reut.rs/3VccreK


Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sumana Nandy, Sonia Cheema and Savio D'Souza

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.